Statsautoriseret fodterapeut BClear ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.8% 0.8% 0.8% 0.8% 0.8%  
Bankruptcy risk  8.4% 5.9% 4.6% 2.9% 3.7%  
Credit score (0-100)  31 39 44 58 51  
Credit rating  BB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  533 79.2 67.5 280 488  
EBITDA  51.7 1.4 2.5 37.8 46.8  
EBIT  51.7 1.4 2.5 27.0 -4.7  
Pre-tax profit (PTP)  50.9 0.2 1.7 26.8 -4.7  
Net earnings  39.1 -0.1 1.1 20.6 0.1  
Pre-tax profit without non-rec. items  50.9 0.2 1.7 26.8 -4.7  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  0.0 0.0 0.0 117 164  
Shareholders equity total  43.0 42.8 43.9 64.5 64.6  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  182 124 154 193 273  

Net Debt  -182 -123 -147 -42.9 -43.7  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  533 79.2 67.5 280 488  
Gross profit growth  0.0% -85.1% -14.8% 314.9% 74.3%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  182 124 154 193 273  
Balance sheet change%  0.0% -31.7% 24.1% 25.3% 41.2%  
Added value  51.7 1.4 2.5 27.0 46.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 107 -5  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 -1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  9.7% 1.8% 3.6% 9.7% -1.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  28.4% 0.9% 1.8% 15.6% -2.0%  
ROI %  120.5% 3.3% 5.7% 47.3% -6.8%  
ROE %  91.0% -0.3% 2.5% 37.9% 0.2%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  23.6% 34.5% 28.5% 33.4% 23.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -351.9% -8,621.0% -5,956.0% -113.5% -93.6%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.2 1.5 1.4 0.6 0.4  
Current Ratio  2.2 1.5 1.4 0.6 0.4  
Cash and cash equivalent  182.1 123.2 146.5 42.9 43.7  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  161.3 42.8 43.9 -47.1 -128.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  52 1 2 27 47  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  52 1 2 38 47  
EBIT / employee  52 1 2 27 -5  
Net earnings / employee  39 -0 1 21 0